BOB体育

Skip to main content
(352) 265-0820

R. David Anderson, MD, MS, FACC, FSCAI

Cardiologist (Heart Specialist), Interventional Cardiologist, Internist

Photo of R. David Anderson
(352) 265-0820 MyUFHealth

Research at a glance

Top areas of exploration

  • Myocardial Infarction , 22 publications
  • Myocardial Ischemia , 15 publications
  • Coronary Artery Disease , 14 publications
  • Coronary Circulation , 10 publications

Research activity

112 publications

7,393 citations

Why is this important?

Active clinical trials

SMART

The purpose of this trial is to generate clinical evidence on valve safety and performance of self-expanding (SE) versus balloon-expandable (BE) transcatheter aortic valve replacement (TAVR) in subjects with a small aortic annulus and symptomatic鈥�

Investigator
R. David Anderson
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All
Cardiamp CMI

Prospective, multi-center, 2:1 randomized (Treatment : Sham Control), sham-controlled, double-blinded trial to compare treatment using the CardiAMP cell therapy system to sham treatment Treatment Group: Subjects treated with aBMC using the CardiAMP鈥�

Investigator
R. David Anderson
Status
Accepting Candidates
Ages
21 Years - 80 Years
Sexes
All

My publications

112 publications

2020

Does ischemia also change as we age?

Jacc-Cardiovascular Interventions

2020

Editorial: The use of Fascia iliaca Block with Minimal Conscious Sedation in Transcatheter Aortic Valve Replacement: Advances in TAVR Anesthesia.

Cardiovascular revascularization medicine : including molecular interventions

鈥�

2020

Incidence, Clinical Presentation, and Causes of 30-Day Readmission Following Hospitalization With Spontaneous Coronary Artery Dissection.

JACC. Cardiovascular interventions

鈥�

2020

Myocardial infarction and persistent angina with no obstructive coronary artery disease

2020

Percutaneous inferior vena cava valve implantation may improve tricuspid valve regurgitation and cardiac output: Lessons learned

Innovations (Philadelphia, Pa. Online)